According to the Zhitong Finance App, Xianjian Technology (01302) announced its 2026 interim results, with revenue of 600.8 million yuan, a year-on-year decrease of 11.2%; loss attributable to the company's owners was 34.348 million yuan, profit of 55.74 million yuan for the same period last year; basic loss of 0.8 points per share.

The year-on-year decrease in earnings during the period was mainly due to a decrease in sales revenue of structural heart disease occlutters and pacemakers.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.